Announcements Trials

Browse Landscape

Sponsor

Conditions

Breast Neoplasms 6 Malignant Solid Neoplasm 1 Inflammatory Breast Neoplasms 1 Esophageal Neoplasms 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms, Male 1 Bladder Urothelial Carcinoma 1 Advanced Breast Carcinoma 1 Adenocarcinoma Of Esophagus 1

Interventions

Paclitaxel 96 Carboplatin 81 Bevacizumab 62 Gemcitabine 36 liposomal doxorubicin 32 pembrolizumab 30 Topotecan 26 olaparib 23 Taxes 23 niraparib 17 Immunoglobulin G 17 Disulfides 17 Docetaxel 16 Cyclophosphamide 16 Cisplatin 14 Nivolumab 11 rucaparib 10 durvalumab 10 Doxorubicin 9 Albumin-Bound Paclitaxel 8 sargramostim 7 pazopanib 7 fludarabine phosphate 7 fludarabine 7 avelumab 7 Magnetic Resonance Spectroscopy 7 Ifosfamide 7 epacadostat 6 Trabectedin 6 Sorafenib 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × trastuzumab biosimilar HLX02 × Clear all

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡